Delaware C-Corporation · Biotechnology and wellness
Rinnovare Labs™ builds and supplies products at the edge of consumer biotechnology — photobiomodulation panels, glutathione supplementation, topicals, and a cell-science programme. We publish what each product is, and we say plainly where the research runs out.
Products
A light-emitting device, a dietary supplement and a topical are governed by different rules, and each carries a different standard of evidence. We keep them separate rather than blending them into one claim.

Device
Eight wavelengths, 1,155 LEDs, 540 W, 72 inches of coverage. Full-body in one session.
$9,995.99
Specifications
Device
The same spectrum in a targeted format, for a single area rather than the whole body.
$3,995.99
Specifications
Supplement
350 mg reduced glutathione per capsule in a CyLoc® octadextrin matrix. 60 capsules.
$29.99 60 capsules
Current inventory. Packaging is being updated.

Topical
A topical gel for daily use, formulated to sit alongside the supplement rather than duplicate it.
$60.00
Biotech
Our first biotechnology product is Muse cells — Multilineage-differentiating Stress-Enduring cells, a rare subpopulation resident in adult connective tissue. We work on this with Pilargo Foundation™, which supplies wholesale to licensed clinics and research groups.
This is a different kind of product from a light panel or a capsule, and it is held to a different standard. Muse cell preparations are investigational. No regulator has approved one, anywhere.
What we will not tell you
That Muse cells have been shown to outperform standard mesenchymal therapy in patients. No head-to-head human trial has ever compared them, for any condition.
Position
Consumer biotechnology has a credibility problem, and it is self-inflicted. Products arrive wrapped in mechanisms that cannot be measured and benefits that were never tested. Buyers have learned to discount everything, including the parts that are real.
So we publish specifications, we cite the literature where it exists, and we say nothing where it does not. On the panels, that means naming the wavelengths where the evidence is strong and the ones where independent studies are thin. It is a less exciting page. It is the one that survives a customer checking it.